Novel Ureteral Stent Catheterization Technique for Treating Hyperchloremic Metabolic Acidosis After Total Pelvic Exenteration.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 20 09 2023
revised: 05 10 2023
accepted: 06 10 2023
medline: 2 11 2023
pubmed: 1 11 2023
entrez: 1 11 2023
Statut: ppublish

Résumé

Hyperchloremic metabolic acidosis after total pelvic exenteration (TPE) is relatively rare. Urinary diversion of the ileal conduit during TPE can result in increased urine reabsorption leading to hyperchloremic metabolic acidosis. We developed a new technique for the retrograde catheterization of a ureteral stent into an ileal conduit to treat hyperchloremic metabolic acidosis. A 70-year-old man underwent TPE for locally recurrent rectal cancer. Multiple episodes of complications, such as hyperchloremia and metabolic acidosis, occurred. Effective drainage of urine from the ileal conduit is crucial. With collaboration between an endoscopist and a radiologist, we developed a novel method for retrograde catheterization of the ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis after TPE. The patient's condition quickly improved after the procedure. Our novel technique of retrograde catheterization of a ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis could be adopted worldwide, as it is effective and safe.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Hyperchloremic metabolic acidosis after total pelvic exenteration (TPE) is relatively rare. Urinary diversion of the ileal conduit during TPE can result in increased urine reabsorption leading to hyperchloremic metabolic acidosis. We developed a new technique for the retrograde catheterization of a ureteral stent into an ileal conduit to treat hyperchloremic metabolic acidosis.
CASE REPORT METHODS
A 70-year-old man underwent TPE for locally recurrent rectal cancer. Multiple episodes of complications, such as hyperchloremia and metabolic acidosis, occurred. Effective drainage of urine from the ileal conduit is crucial. With collaboration between an endoscopist and a radiologist, we developed a novel method for retrograde catheterization of the ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis after TPE. The patient's condition quickly improved after the procedure.
CONCLUSION CONCLUSIONS
Our novel technique of retrograde catheterization of a ureteral stent into an ileal conduit for hyperchloremic metabolic acidosis could be adopted worldwide, as it is effective and safe.

Identifiants

pubmed: 37909985
pii: 43/11/5149
doi: 10.21873/anticanres.16715
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5149-5153

Informations de copyright

Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Koji Komori (K)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan; kkomori@aichi-cc.jp.

Tsutomu Tanaka (T)

Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan.

Yoshitaka Inaba (Y)

Department of Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan.

Takashi Kinoshita (T)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Yusuke Sato (Y)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Akira Ouchi (A)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Seiji Ito (S)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Tetsuya Abe (T)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Kazunari Misawa (K)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Yuichi Ito (Y)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Seiji Natsume (S)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Eiji Higaki (E)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Tomonari Asano (T)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Masataka Okuno (M)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Hironori Fujieda (H)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Satoru Akaza (S)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Hisahumi Saito (H)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Kiyoshi Narita (K)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Takuya Kitahara (T)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Takaaki Hanazawa (T)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Hidenori Ojio (H)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Masashi Negita (M)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Yasuhiro Shimizu (Y)

Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH